Ethocle Reports has published its latest Market Research Report on Transdermal Drug Delivery - Medical Devices Pipeline Assessment, 2016. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Browse market data tables and figures.

1. Transdermal Drug Delivery- Medical DevicesPipeline Assessment,2016
Ethocle Reportshaspublished its latest MarketResearch Reporton Transdermal Drug Delivery- Medical
DevicesPipeline Assessment,2016. Identify emerging playerswith potentially strong productportfolio
and create effectivecounter-strategiesto gain competitiveadvantage.Browsemarketdata tablesand
figures.
PublishedOn: 01-Dec-2016 | Pages: 421
Summary
GlobalData'sMedical Devicessectorreport,“Transdermal DrugDelivery - Medical DevicesPipeline
Assessment,2016" providesanoverview of Transdermal DrugDeliverycurrentlyinpipeline stage.
The report providescomprehensiveinformationonthe pipeline productswithcomparative analysisof
the productsat variousstagesof development.The reportreviewsmajorplayersinvolvedinthe pipeline
productdevelopment.Italsoprovidesinformationaboutclinical trialsinprogress,whichincludestrial
phase,trial status,trial start and enddates,and,the numberof trialsfor the keyTransdermal Drug
Deliverypipelineproducts.
Thisreportis preparedusingdatasourcedfromin-house databases,secondaryandprimaryresearchby
GlobalData'steamof industryexperts.
*Note:Certainsectionsinthe reportmaybe removedoralteredbasedonthe availabilityandrelevance
of data inrelationtothe equipmenttype.
Click here to find out more about this report?
Scope
- Extensive coverage of the Transdermal DrugDeliveryunderdevelopment
- The report reviewsdetailsof majorpipeline productswhichincludes,productdescription,licensing
and collaborationdetailsandotherdevelopmental activities

2. - The report reviewsthe majorplayersinvolvedinthe developmentof Transdermal DrugDeliveryand
listall theirpipeline projects
- The coverage of pipeline productsbasedonvariousstagesof developmentrangingfromEarly
DevelopmenttoApproved/Issuedstage
- The report provideskeyclinical trial dataof ongoingtrialsspecifictopipeline products
- Recentdevelopments inthe segment/industry
Get Free Sample Report
Click here for Discounts
Reasons to buy
The report enablesyouto -
- Formulate significantcompetitorinformation,analysis,andinsightstoimprove R&Dstrategies
- Identifyemergingplayerswithpotentiallystrongproductportfolioandcreate effective counter-
strategiestogaincompetitiveadvantage
- Identifyandunderstandimportantanddiversetypes of Transdermal DrugDeliveryunderdevelopment
- Developmarket-entryandmarketexpansionstrategies
- Planmergersandacquisitionseffectivelybyidentifyingmajorplayerswiththe mostpromisingpipeline
- In-depthanalysisof the product’scurrentstage of development,territoryandestimatedlaunchdate
Table of Contents
1.1 Listof Tables10
1.2 Listof Figures19
2 Introduction20
2.1 Transdermal DrugDeliveryOverview20
3 ProductsunderDevelopment21
3.1 Transdermal DrugDelivery - PipelineProductsbyStage of Development21

3. 3.2 Transdermal DrugDelivery - PipelineProductsbySegment22
3.3 Transdermal DrugDelivery - PipelineProductsbyTerritory23
3.4 Transdermal DrugDelivery - PipelineProductsbyRegulatoryPath24
3.5 Transdermal DrugDelivery - PipelineProductsbyEstimatedApproval Date 25
3.6 Transdermal DrugDelivery - OngoingClinical Trials26
4 Transdermal DrugDelivery - Pipeline ProductsunderDevelopmentbyCompanies27
4.1 Transdermal DrugDeliveryCompanies - Pipeline ProductsbyStage of Development27
4.2 Transdermal DrugDelivery - PipelineProductsbyStage of Development31
5 Transdermal DrugDeliveryCompaniesandProductOverview 35
5.1 3M CompanyCompanyOverview35
5.2 AequusPharmaceuticalsIncCompanyOverview 37
5.3 Agile TherapeuticsIncCompanyOverview 41
5.4 AllerganPlcCompanyOverview 47
5.5 AlliquaBioMedical IncCompanyOverview 49
5.6 AlteaTherapeuticsCorporation(Inactive)CompanyOverview 51
5.7 AnteriosIncCompanyOverview54
5.8 Apogee Technology IncCompanyOverview 55
5.9 AvroLife SciencesCompanyOverview 56
5.10 AxxiaPharmaceuticals,LLCCompanyOverview 57
5.11 Burke PharmaceuticalsLLCCompanyOverview 58
5.12 CarbylanTherapeuticsIncCompanyOverview 60
5.13 CerimonPharmaceuticals,Inc. (Inactive) CompanyOverview 61
5.14 CoriumInternational IncCompanyOverview 62
5.15 DBV TechnologiesSA CompanyOverview 67
5.16 Dermisonics,Inc.CompanyOverview 69

4. 5.17 Dharma Therapeutics,Inc.(Inactive) CompanyOverview 71
5.18 DURECT Corp Company Overview72
5.19 Echo TherapeuticsIncCompanyOverview 74
5.20 ExploitTechnologiesPte LtdCompanyOverview 76
5.21 ExtendBiosciencesIncCompanyOverview 77
5.22 EyeGate PharmaceuticalsIncCompanyOverview 78
5.23 Fe3 Medical Inc CompanyOverview83
5.24 FluGenInc CompanyOverview84
5.25 FrenchNational Institute of HealthandMedical ResearchCompanyOverview 85
5.26 HisamitsuPharmaceutical CoIncCompanyOverview86
5.27 ImmuPatchCompanyOverview93
5.28 Imperial College LondonCompanyOverview 95
5.29 IndianInstitute of TechnologyBombayCompanyOverview96
5.30 Intercell AG(Inactive) CompanyOverview97
5.31 Interstitial NSCompanyOverview98
5.32 IsisBiopolymer,Inc.CompanyOverview 99
5.33 JanisysCompanyOverview102
5.34 MassachusettsInstitute of TechnologyCompanyOverview103
5.35 Meda AB CompanyOverview 104
5.36 MedherantLtd CompanyOverview 106
5.37 MEDRx Co.,Ltd CompanyOverview 107
5.38 mesoesteticUSA Inc CompanyOverview112
5.39 MicropointTechnologiesPte LtdCompanyOverview113
5.40 National TaiwanOceanUniversityCompanyOverview 114
5.41 NeuroDermLtdCompanyOverview115

5. 5.42 NittoDenkoCorp CompanyOverview 122
5.43 North CarolinaState UniversityCompanyOverview124
5.44 NovosanisNV CompanyOverview126
5.45 NuvoPharmaceuticalsIncCompanyOverview 127
5.46 OldDominionUniversityCompanyOverview 129
5.47 PantecBiosolutionsAGCompanyOverview130
5.48 PhosphagenicsLtdCompanyOverview 131
5.49 Purdue UniversityCompanyOverview 135
5.50 RadiusHealthInc CompanyOverview136
5.51 Ratio Inc CompanyOverview138
5.52 Scilex LtdCompanyOverview 139
5.53 Sensile Medical AGCompanyOverview 140
5.54 SkinjectIncCompanyOverview 141
5.55 SolasiaPharmaKK CompanyOverview 142
5.56 Sparsha PharmaInternational PvtLtdCompanyOverview 143
5.57 Sparsha PharmaUSA Inc CompanyOverview 145
5.58 StanfordUniversityCompanyOverview 146
5.59 SumitomoDainipponPharmaCoLtdCompanyOverview 147
5.60 SyntropharmaLtd CompanyOverview149
5.61 TeikokuSeiyakuCoLtdCompanyOverview 150
5.62 tesa LabtecGmbH CompanyOverview 151
5.63 Teva Pharmaceutical IndustriesLtdCompanyOverview152
5.64 TheraJectInc CompanyOverview 153
5.65 TheraSolve NV CompanyOverview155
5.66 Theratech,Inc.CompanyOverview 157

6. 5.67 Titan PharmaceuticalsIncCompanyOverview 158
5.68 Transcu Group Limited(Inactive) CompanyOverview 161
5.69 Transdermal DeliverySolutionsCorpCompanyOverview162
5.70 TransPharma Medical Ltd CompanyOverview 163
5.71 Transport PharmaceuticalsIncCompanyOverview 165
5.72 Univec,Inc. (Inactive) CompanyOverview 166
5.73 Universityof IllinoisatChicagoCompanyOverview 169
5.74 Universityof TorontoCompanyOverview170
5.75 Vyteris,Inc.(Inactive)CompanyOverview 171
5.76 ZambonItaliaSrl CompanyOverview 172
5.77 Z-Cube Srl CompanyOverview 173
5.78 ZosanoPharma Corp CompanyOverview 174
5.79 ZynerbaPharmaceuticalsIncCompanyOverview 178
6 Transdermal DrugDelivery- RecentDevelopments182
6.1 Nov22, 2016: MedtronicReportsSecond QuarterFinancial Results182
6.2 Nov22, 2016: Innocoll AnnouncesThirdQuarter2016 Financial andOperatingResultsandProvides
Corporate Update 184
6.3 Nov21, 2016: CoriumReportsFourthQuarterand Fiscal Year 2016 Financial ResultsandRecent
Corporate Highlights187
6.4 Nov17, 2016: AequusPreparesforProof of ConceptClinical StudyforTransdermalAnti-Nausea
DiclegisProgram188
6.5 Nov16, 2016: MedtronicReleasesFY16IntegratedPerformanceReport189
6.6 Nov16, 2016: NuvoPharmaceuticalsappointsnew president189
6.7 Nov16, 2016: NuvoPharmaceuticalsAppointsJesse LedgerasPresident190
6.8 Nov15, 2016: TevaReportsThirdQuarter 2016 Results190
6.9 Nov15, 2016: Cynosure HealthWelcomesThree New BoardMembers192
6.10 Nov15, 2016: CEVA to work withMedtronicfordistributionfacilityconstruction193

7. 6.11 Nov14, 2016: Adriane M. Brownto JoinAllerganBoardof Directors193
6.12 Nov11, 2016: SumitomoDainipponPharmaAnnouncesOrganizationalRealignmentandChanges
RelatedtoOfficersandOtherKeyPositions194
6.13 Nov10, 2016: PhosphagenicsExtendsDue Diligence PeriodforOpioidPatchesinJapan196
6.14 Nov10, 2016: NuvoPharmaceuticalsAnnounces2016 Third QuarterResults196
6.15 Nov10, 2016: Valeritas ReportsThirdQuarter2016 Financial Results198
6.16 Nov09, 2016: AntaresPharmaReportsThird Quarter2016 Financial andOperatingResults199
6.17 Nov09, 2016: ZosanoPharma ReportsThirdQuarter 2016 Financial Results201
6.18 Nov08, 2016: Teva AnnouncesAppointmentof New Chief Legal Officer202
6.19 Nov07, 2016: Agile TherapeuticsReportsThirdQuarter2016 Financial Results202
6.20 Nov07, 2016: Camurus:InterimreportJanuary-September2016 203
6.21 Nov04, 2016: AlliquaBioMedical ReportsThirdQuarterandNine-MonthsFiscal Year2016 Financial
Results204
6.22 Nov03, 2016: LannettReportsFiscal 2017 First-QuarterFinancial Results206
6.23 Nov03, 2016: Revance ReleasesThirdQuarter2016 Results207
6.24 Nov03, 2016: RadiusHealthReports ThirdQuarter 2016 Financial andOperatingResults208
6.25 Nov02, 2016: AllerganReportsThirdQuarter2016 ContinuingOperationsPerformance withGAAP
NetRevenuesof $3.6 Billion;AnnouncesAcceleratedShare Repurchase,Initiationof CashDividend211
6.26 Nov02, 2016: EyeGate PharmaceuticalsReportsThirdQuarter2016 Financial ResultsandProvides
BusinessUpdate 215
6.27 Nov01, 2016: Cynosure PromotesDougDelaneytoChief Commercial Officer216
6.28 Oct 31, 2016: DURECT AnnouncesThirdQuarter2016 Financial ResultsandUpdate of Programs
216
6.29 Oct 31, 2016: AntaresPharmaAppointsFredM. Powell,SeniorVice PresidentandChief Financial
Officer217
6.30 Oct 28, 2016: Probuphine ImplantforOpioidDependence Featuredat2016 International Societyof
AddictionMedicineMeeting218
6.31 Oct 27, 2016: Probuphine WinsPopularScience's"Bestof What'sNew"Award219

8. 6.32 Oct 26, 2016: AllerganAnnouncesChangestoBoardLeadership219
6.33 Oct 26, 2016: GlaxoSmithKline:ResultsAnnouncementforthe thirdquarter2016 220
6.34 Oct 26, 2016: The MedicinesCompanyReportsThird-Quarter2016 Financial Results226
6.35 Oct 25, 2016: Cynosure AnnouncesRecordThird-QuarterRevenues;RevenuesIncrease 36Percent
fromPrior Year to$106.4 Million227
6.36 Oct 25, 2016: LillyReportsThird-Quarter2016 Results228
6.37 Oct 20, 2016: JDRF and the Universityof Torontosupportresearchintoa skinpatchto prevent
common,life-threateningriskof T1D 233
6.38 Oct 17, 2016: AequusAdvancesClinical Developmentof Transdermal AripiprazolePatch233
6.39 Oct 17, 2016: HisamitsuAmerica,the Global Leaderof Topical PainPatches,Introducesthe
SalonpasLidocaine 4%PainRelievingGel-Patch234
6.40 Oct 17, 2016: ZynerbaProvidesClinical Update forLeadDevelopment Candidate ZYN001234
6.41 Oct 17, 2016: BraeburnPharmaceuticalstoConductSeriesof Probuphine(buprenorphine)Implant
TrainingsinSaltLake CityonOctober 27-29, 2016 forQualifiedHealthcare Providers235
6.42 Oct 05, 2016: AlliquaBioMedical AnnouncesPreliminaryThirdQuarterof Fiscal Year2016 Revenue
235
6.43 Oct 05, 2016: NewStudyShowcasesEconomicImpactof Allergan'sOperationsonNew Jersey
Economy236
6.44 Oct 05, 2016: AlliquaBioMedical AnnouncesPreliminaryThirdQuarterof Fiscal Year2016 Revenue;
EarningsConference Call ScheduledforNovember4th237
6.45 Oct 03, 2016: NovenAppointsRalphLipp,PH.D.,asVice PresidentandChief ScientificOfficer237
6.46 Sep29, 2016: GlaxoSmithKlineappointsBrianMcNamaraas CEO of GSK ConsumerHealthcare 238
6.47 Sep28, 2016: Edward D. Kobus,Presidentof InvadoPharmaceuticals,JoinsTransdermal Delivery
SolutionsBoardof Advisors238
6.48 Sep27, 2016: PremierBiomedical PainManagementSolutionsAnnouncesShipmentof Initial
Samplesof Opioid-Free,50-State Legal,Cannabis-BasedPain-RelievingTopical Patch239
6.49 Sep27, 2016: MedherantRaisesUSD2 MillioninVenture Financing239
6.50 Sep22, 2016: LannettAnnouncesResignationOf MahendraDedhiya,Ph.D.,ChiefOf Scientific
Affairs240

9. 6.51 Sep22, 2016: IndustryVeteranKatherineD.Crothall,PhDtoJoinValeritasBoardof Directors240
6.52 Sep20, 2016: ALZYN EntersintoLicensingAgreementwithTransdermal DeliverySolutions240
6.53 Sep20, 2016: Emma WalmsleytosucceedAndrew WittyasChief Executive Officerof
GlaxoSmithKline 241
6.54 Sep19, 2016: NeuroDermtoPresentND0612H Data at 4th WorldParkinsonCongress241
6.55 Sep19, 2016: NeuroDermtoPresentND0612L Data at 4th WorldParkinsonCongress
DemonstratingEase of Use of Mini-PumpDeliverySystem242
6.56 Sep19, 2016: RadiusPresentsAbaloparatide Transdermal PatchDevelopmentProgramat
AmericanSocietyforBone andMineral Research2016 Annual Meeting243
6.57 Sep15, 2016: MedtronicNamesMark Ploof SeniorVice Presidentof Global Operationsand
BusinessServices244
6.58 Sep14, 2016: Levi Garraway, M.D., Ph.D.,tobecome SeniorVice Presidentof Global Oncologyat
Lilly,SucceedingRichardGaynor,M.D.,Who isRetiringaftera DistinguishedCareer245
6.59 Sep13, 2016: Cynosure toName StephenJ.WebberasNew Chief Financial Officer245
6.60 Sep08, 2016: ChronoTherapeuticsRaisesUSD47.6 MillioninSeriesBFinancing246
6.61 Sep08, 2016: ZosanoAppointsGeorgiaErbezas Chief BusinessOfficer246
6.62 Sep07, 2016: NovenAnnouncesAppointmentof Jeff MihmtoitsBoard of Directors246
6.63 Sep06, 2016: AequusPharmaRaisesUSD2 MillioninPublicOfferingof Shares247
6.64 Sep01, 2016: NuvoPharmaceuticalsAppointsNew Chief Financial Officer247
6.65 Aug 31, 2016: Jamere JacksonElectedToLillyBoardOf Directors247
6.66 Aug 30, 2016: AequusProvidesCorporate Update onCommercial andDevelopmentPrograms248
6.67 Aug 25, 2016: Wallace K.Reams,FormerPresidentof AvevaDrugDeliverySystemsJoins
Transdermal DeliverySolutionsBoardof Advisors250
6.68 Aug 25, 2016: MedtronicReportsFirstQuarterFinancial Results250
6.69 Aug 24, 2016: Acrux:Financial Reportforthe yearended30 June 2016 253
6.70 Aug 23, 2016: LannettAnnouncesRecordNetSalesForFiscal 2016 Fourth-QuarterAndFull-Year
254
6.71 Aug 16, 2016: ValeritasAppointsErickJ.Luceraas Chief Financial Officer255

10. 6.72 Aug 12, 2016: Echo TherapeuticsAnnouncesSecondQuarter2016 Financial Results255
6.73 Aug 10, 2016: EyeGate PharmaceuticalsReportsSecondQuarter2016 Financial Resultsand
ProvidesBusinessUpdate 256
6.74 Aug 10, 2016: LillyannouncesJoshuaSmiley,AnatAshkenazi appointedtonew roles,ThomasGrein
retires257
6.75 Aug 10, 2016: NuvoPharmaceuticalsAnnounces2016 SecondQuarterResults258
6.76 Aug 10, 2016: ZosanoPharmaReportsSecondQuarter2016 Financial Results259
6.77 Aug 10, 2016: ValeritasReportsSecondQuarter2016 Financial Results260
6.78 Aug 09, 2016: AlliquaBioMedical ReportsSecondQuarterandSix MonthsFiscal Year 2016 Financial
Results261
6.79 Aug 09, 2016: AntaresPharmaReportsSecondQuarter2016 OperatingandFinancial Results263
6.80 Aug 09, 2016: EDA BoardActs to Encourage Global Pharmaceutical CompanyAllergantoExpandin
NewJersey264
6.81 Aug 08, 2016: Fe3Medical RaisesAdditionalUSD3.5 MillioninSeriesBFinancingRound265
6.82 Aug 08, 2016: AllerganReportsStrongSecondQuarter2016 ContinuingOperationsPerformance
withNetRevenuesof $3.7 Billion265
6.83 Aug 08, 2016: Agile TherapeuticsReportsSecondQuarter2016 Financial Results269
6.84 Aug 05, 2016: AequusAnnouncesAdvancementof Anti-NauseaTransdermal Extended-Release
PatentApplication270
6.85 Aug 04, 2016: TevaReportsSecondQuarter2016 Results271
6.86 Aug 04, 2016: RadiusHealthReportsSecondQuarter2016 Financial andOperatingResults275
6.87 Aug 04, 2016: Revance ReleasesSecondQuarter2016 Results277
6.88 Aug 04, 2016: CoriumReportsThirdQuarterFiscal 2016 Financial ResultsandRecentCorporate
Highlights278
6.89 Aug 02, 2016: BraeburnPharmaceuticalstoConductFirstSeriesof Probuphine (buprenorphine)
ImplantTrainingsinSanJuan onAugust5, 6 and 7 forQualifiedHealthcare Providers279
6.90 Aug 01, 2016: DURECT AnnouncesSecondQuarter2016 Financial ResultsandUpdate of Programs
280
7 Appendix416

11. 7.1 Methodology416
7.2 AboutGlobalData419
7.3 Contact Us 419
7.4 Disclaimer419